Prezentare generală
RBC-engager for NK and T cell activation in cancer immunotherapy (REAKT), PNRR/2022/C9/MCID/I8, contract de finanțare 760103/23.05.2023, cod proiect CF 227/29.11.2022 (2023-2026).
2023-2026
Contract de finanțare 760103/23.05.2023
PNRR/2022/C9/MCID/I8
RBC-engager for NK and T cell activation in cancer immunotherapy (REAKT), PNRR/2022/C9/MCID/I8, contract de finanțare 760103/23.05.2023, cod proiect CF 227/29.11.2022 (2023-2026).